Beta Bionics, Inc

Aethlon Medical is the developer of the Hemopurifier, a first-in-class medical device to treat infectious disease. The Hemopurifier addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. The Hemourifier is a novel multi-patented platform technology designed for the single use removal of viral pathogens from blood. Regulatory and commercialization initiatives in the United States are focused on bioterror threats, while international initiatives are directed towards naturally evolving pandemic threats, and chronic infectious disease conditions including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). Aethlon Medical is located in San Diego.

INOVIO Pharmaceuticals is a clinical-stage biotechnology company based in San Diego, CA, dedicated to developing innovative DNA medicines to combat HPV-related diseases, cancer, and infectious diseases. Their proprietary technology utilizes optimized design and delivery of DNA plasmids, which act as software for the body's cells to produce specific disease-fighting proteins. With a focus on scientific excellence and operational expertise, INOVIO aims to redefine treatment paradigms and improve lives globally. Driven by cutting-edge technology and a commitment to patient well-being, INOVIO harnesses the power of DNA medicine to revolutionize healthcare. Their research and development efforts are centered on advancing next-generation therapies with groundbreaking potential, leveraging the versatility, immunogenicity, and scalability of DNA medicines. By utilizing their proprietary CELLECTRA delivery devices, INOVIO ensures optimal effect without the need for chemical adjuvants or nanoparticles, setting them apart from viral vector platforms and minimizing the risk of anti-vector response. Through their dedication to transforming treatment approaches, INOVIO is poised to make a significant impact in the field of biotechnology.Generated from the website

Inovio Biomedical Corporation is a biotechnology company that develops a variety of vaccines to prevent and treat cancers and chronic infectious diseases. The company specializes in the development of DNA delivery solutions based on electroporation Its DNA delivery technology increases gene expression and immune responses from DNA vaccines. Inovio Biomedical Corporation s immunotherapy partners include Merck, Wyeth, Vical, the University of Southampton, Moffitt Cancer Center, the National Cancer Institute and International Aids Vaccine Initiative. The company offers pulse generators and handheld applicators to create optimal methods and conditions for facilitating DNA vaccine delivery. Founded in 1983, it develops vaccines for various diseases, such as HIV and hepatitis C.